Literature DB >> 71268

Radioimmunoassay for the antigenic determinants of cholera toxin and its components.

K E Hejtmancik, J W Peterson, D E Markel, A Kurosky.   

Abstract

A radioimmunoassay procedure is described for the detection of cholera toxin and its component polypeptide chains. Cholera toxin, A subunit, B subunit, alpha chain, and gamma chain were iodinated by the chloramine T procedure. Radiolabeling did not significantly alter the polyacrylamide electrophoretic migration patterns of the toxin or its components. Moreover, radiolabeled toxin, B subunit, and alpha chain preparations retained substantial ability to bind to intestinal mucosal homogenates. The minimal amount of antitoxin detectable with radiolabeled toxin was 0.04 antitoxin units/ml. Substitution of radiolabeled B subunit, A subunit, and alpha chain for radiolabeled toxin decreased the sensitivity of the test. Radiolabeled gamma chain did not bind to the antitoxin preparation. Competitive inhibition studies, with titrated anti-choleragen serum and radiolabeled toxin or components, indicated that the minimum concentration of toxin detectable was 7.0 x 10(-8) mumol/ml at a 90% inhibition level. The A subunit and alpha chain preparations inhibited the binding of the radiolabeled B subunit to antitoxin sites. Conversely, B subunit inhibited the binding of radiolabeled A subunit and alpha chain to antitoxin. The gamma chain did not show any reaction with antitoxin or cross-reaction with either whole toxin or its components. These results strongly suggest that the A subunit and the alpha chain contain antigenic determinant(s) that are common to the B subunit. The B subunit (beta chain) and the alpha chain of cholera toxin may therefore contain region(s) of chemical similarity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71268      PMCID: PMC421172          DOI: 10.1128/iai.17.3.621-628.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  The arrangement of subunits in cholera toxin.

Authors:  D M Gill
Journal:  Biochemistry       Date:  1976-03-23       Impact factor: 3.162

2.  Short communications. Subunit A from cholera toxin is an activator of adenylate cyclase in pigeon erythrocytes.

Authors:  S Van Heyningen; C A King
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

3.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

4.  Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae.

Authors:  S N DE
Journal:  Nature       Date:  1959-05-30       Impact factor: 49.962

5.  Activities of bacteria-free preparations from Vibrio cholerae.

Authors:  S N DE; M L GHOSE; A SEN
Journal:  J Pathol Bacteriol       Date:  1960-04

6.  Role of cholera a toxin in experimental cholera.

Authors:  N K DUTTA; M V PANSE; D R KULKARNI
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

7.  The mechanism of action of cholera toxin in pigeon erythrocyte lysates.

Authors:  D M Gill; C A King
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

8.  Multiple roles of erythrocyte supernatant in the activation of adenylate cyclase by Vibrio cholerae toxin in vitro.

Authors:  D M Gill
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

9.  Enterotoxins of Escherichia coli and vibriocholerae: tools for the molecular biologist.

Authors:  H S Kantor
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

10.  Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).

Authors:  R A Finkelstein; M Boesman; S H Neoh; M K LaRue; R Delaney
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

View more
  16 in total

1.  Cloning and expression of the Salmonella enterotoxin gene.

Authors:  A K Chopra; C W Houston; J W Peterson; R Prasad; J J Mekalanos
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

2.  Protection against experimental cholera by oral or parenteral immunization.

Authors:  J W Peterson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

Review 3.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

4.  Characterization of Salmonella toxin released by mitomycin C-treated cells.

Authors:  C W Houston; F C Koo; J W Peterson
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.

Authors:  C O Jacob; M Sela; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Characterization of the antigenic determinants of cholera toxin subunits.

Authors:  D E Markel; K E Hejtmancik; J W Peterson; F B Martin; A Kurosky
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

7.  Quantitative detection of Vibrio cholera toxin by real-time and dynamic cytotoxicity monitoring.

Authors:  Dazhi Jin; Yun Luo; Min Zheng; Haijing Li; Jing Zhang; Melinda Stampfl; Xiao Xu; Gangqiang Ding; Yanjun Zhang; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

8.  Radial passive immune hemolysis assay for detection of heat-labile enterotoxin produced by individual colonies of Escherichia coli or Vibrio cholerae.

Authors:  M G Bramucci; R K Holmes
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

9.  Characterization of monoclonal antibodies that react with unique and cross-reacting determinants of cholera enterotoxin and its subunits.

Authors:  R K Holmes; E M Twiddy
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Cholera toxin-like toxin released by Salmonella species in the presence of mitomycin C.

Authors:  N C Molina; J W Peterson
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.